ArticlePloS one2014

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.

Esther Conde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.